| Trial name or title |
Efficacy and safety study of celecoxib and pregabalin compared with celecoxib monotherapy, in patients with chronic low back pain having a neuropathic component |
| Methods |
Randomised, double‐blind, parallel groups, placebo‐controlled |
| Participants |
Chronic low back pain with high probability of a significant neuropathic component for 4 years or less |
| Interventions |
Pregabalin and celecoxib, placebo and celecoxib |
| Outcomes |
A range of pain outcomes, depression, sleep |
| Starting date |
October 2013 |
| Contact information |
Pfizer |
| Notes |
Recruitment terminated on 3 April 2015 due to slow recruitment rate and lack of operational feasibility. Study was not terminated for reasons of safety or efficacy. |
